Letter to the editor
Immune therapy trials for malignant brain tumors are challenging to undertake and there are many factors, including the high expense per patient which limits the number of patients enrolled, hence curtailing the ability to demonstrate that the intervention improves clinical outcomes. Profiling the i...
Gespeichert in:
| Veröffentlicht in: | Journal for immunotherapy of cancer 2014-07, Vol.2 (1) |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 1 |
| container_start_page | |
| container_title | Journal for immunotherapy of cancer |
| container_volume | 2 |
| creator | Fadul, Camilo E Fisher, Jan L Hampton, Thomas H Ernstoff, Marc S |
| description | Immune therapy trials for malignant brain tumors are challenging to undertake and there are many factors, including the high expense per patient which limits the number of patients enrolled, hence curtailing the ability to demonstrate that the intervention improves clinical outcomes. Profiling the immune cell populations in peripheral blood by flow cytometry is a potentially useful tool, and hierarchical clustering analysis of the multiple cell populations measured may provide a distinct and comprehensive overview of the immune status [2]. J Immuno Ther Cancer. 2013; 1: 7–18. doi:10.1186/2051-1426-1-7 3 Fadul CE, Fisher JL, Hampton TH, Lallana EC, Li Z, Gui J, Szczepiorkowski ZM, Tosteson TD, Rhodes CH, Wishart HA, Lewis LD, Ernstoff MS. Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy. |
| doi_str_mv | 10.1186/2051-1426-2-22 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2638091154</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2638091154</sourcerecordid><originalsourceid>FETCH-proquest_journals_26380911543</originalsourceid><addsrcrecordid>eNpjYBAzNNAzNLQw0zcyMDXUNTQxMtM10jUyYmLghAtwMPAWF2cZGBgYGhgbW1hYcDKI-KSWlKQWKZTkK5RkpCqkpmSW5BfxMLCmJeYUp_JCaW4GZTfXEGcP3YKi_MLS1OKS-Kz80qI8oFS8kZmxhYGloaGpiTFxqgAowyy1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2638091154</pqid></control><display><type>article</type><title>Letter to the editor</title><source>BMJ Open Access Journals</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Springer Nature OA Free Journals</source><creator>Fadul, Camilo E ; Fisher, Jan L ; Hampton, Thomas H ; Ernstoff, Marc S</creator><creatorcontrib>Fadul, Camilo E ; Fisher, Jan L ; Hampton, Thomas H ; Ernstoff, Marc S</creatorcontrib><description>Immune therapy trials for malignant brain tumors are challenging to undertake and there are many factors, including the high expense per patient which limits the number of patients enrolled, hence curtailing the ability to demonstrate that the intervention improves clinical outcomes. Profiling the immune cell populations in peripheral blood by flow cytometry is a potentially useful tool, and hierarchical clustering analysis of the multiple cell populations measured may provide a distinct and comprehensive overview of the immune status [2]. J Immuno Ther Cancer. 2013; 1: 7–18. doi:10.1186/2051-1426-1-7 3 Fadul CE, Fisher JL, Hampton TH, Lallana EC, Li Z, Gui J, Szczepiorkowski ZM, Tosteson TD, Rhodes CH, Wishart HA, Lewis LD, Ernstoff MS. Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy.</description><identifier>EISSN: 2051-1426</identifier><identifier>DOI: 10.1186/2051-1426-2-22</identifier><language>eng</language><publisher>London: BMJ Publishing Group LTD</publisher><subject>Brain cancer ; Cancer ; Cancer therapies ; Clinical trials ; Dendritic cells ; Immunotherapy ; Medical prognosis ; Tumors</subject><ispartof>Journal for immunotherapy of cancer, 2014-07, Vol.2 (1)</ispartof><rights>2014 Fadul et al.; licensee BioMed Central Ltd This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27903,27904</link.rule.ids></links><search><creatorcontrib>Fadul, Camilo E</creatorcontrib><creatorcontrib>Fisher, Jan L</creatorcontrib><creatorcontrib>Hampton, Thomas H</creatorcontrib><creatorcontrib>Ernstoff, Marc S</creatorcontrib><title>Letter to the editor</title><title>Journal for immunotherapy of cancer</title><description>Immune therapy trials for malignant brain tumors are challenging to undertake and there are many factors, including the high expense per patient which limits the number of patients enrolled, hence curtailing the ability to demonstrate that the intervention improves clinical outcomes. Profiling the immune cell populations in peripheral blood by flow cytometry is a potentially useful tool, and hierarchical clustering analysis of the multiple cell populations measured may provide a distinct and comprehensive overview of the immune status [2]. J Immuno Ther Cancer. 2013; 1: 7–18. doi:10.1186/2051-1426-1-7 3 Fadul CE, Fisher JL, Hampton TH, Lallana EC, Li Z, Gui J, Szczepiorkowski ZM, Tosteson TD, Rhodes CH, Wishart HA, Lewis LD, Ernstoff MS. Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy.</description><subject>Brain cancer</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Clinical trials</subject><subject>Dendritic cells</subject><subject>Immunotherapy</subject><subject>Medical prognosis</subject><subject>Tumors</subject><issn>2051-1426</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpjYBAzNNAzNLQw0zcyMDXUNTQxMtM10jUyYmLghAtwMPAWF2cZGBgYGhgbW1hYcDKI-KSWlKQWKZTkK5RkpCqkpmSW5BfxMLCmJeYUp_JCaW4GZTfXEGcP3YKi_MLS1OKS-Kz80qI8oFS8kZmxhYGloaGpiTFxqgAowyy1</recordid><startdate>20140701</startdate><enddate>20140701</enddate><creator>Fadul, Camilo E</creator><creator>Fisher, Jan L</creator><creator>Hampton, Thomas H</creator><creator>Ernstoff, Marc S</creator><general>BMJ Publishing Group LTD</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20140701</creationdate><title>Letter to the editor</title><author>Fadul, Camilo E ; Fisher, Jan L ; Hampton, Thomas H ; Ernstoff, Marc S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_26380911543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Brain cancer</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Clinical trials</topic><topic>Dendritic cells</topic><topic>Immunotherapy</topic><topic>Medical prognosis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fadul, Camilo E</creatorcontrib><creatorcontrib>Fisher, Jan L</creatorcontrib><creatorcontrib>Hampton, Thomas H</creatorcontrib><creatorcontrib>Ernstoff, Marc S</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Journal for immunotherapy of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fadul, Camilo E</au><au>Fisher, Jan L</au><au>Hampton, Thomas H</au><au>Ernstoff, Marc S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Letter to the editor</atitle><jtitle>Journal for immunotherapy of cancer</jtitle><date>2014-07-01</date><risdate>2014</risdate><volume>2</volume><issue>1</issue><eissn>2051-1426</eissn><abstract>Immune therapy trials for malignant brain tumors are challenging to undertake and there are many factors, including the high expense per patient which limits the number of patients enrolled, hence curtailing the ability to demonstrate that the intervention improves clinical outcomes. Profiling the immune cell populations in peripheral blood by flow cytometry is a potentially useful tool, and hierarchical clustering analysis of the multiple cell populations measured may provide a distinct and comprehensive overview of the immune status [2]. J Immuno Ther Cancer. 2013; 1: 7–18. doi:10.1186/2051-1426-1-7 3 Fadul CE, Fisher JL, Hampton TH, Lallana EC, Li Z, Gui J, Szczepiorkowski ZM, Tosteson TD, Rhodes CH, Wishart HA, Lewis LD, Ernstoff MS. Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy.</abstract><cop>London</cop><pub>BMJ Publishing Group LTD</pub><doi>10.1186/2051-1426-2-22</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 2051-1426 |
| ispartof | Journal for immunotherapy of cancer, 2014-07, Vol.2 (1) |
| issn | 2051-1426 |
| language | eng |
| recordid | cdi_proquest_journals_2638091154 |
| source | BMJ Open Access Journals; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Springer Nature OA Free Journals |
| subjects | Brain cancer Cancer Cancer therapies Clinical trials Dendritic cells Immunotherapy Medical prognosis Tumors |
| title | Letter to the editor |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T07%3A28%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Letter%20to%20the%20editor&rft.jtitle=Journal%20for%20immunotherapy%20of%20cancer&rft.au=Fadul,%20Camilo%20E&rft.date=2014-07-01&rft.volume=2&rft.issue=1&rft.eissn=2051-1426&rft_id=info:doi/10.1186/2051-1426-2-22&rft_dat=%3Cproquest%3E2638091154%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2638091154&rft_id=info:pmid/&rfr_iscdi=true |